7th ICHNO Programme Book

PROFFERED PAPERS Proffered papers 3 10:30 - 11:30 | Auditorium Chair: S. Oosting (The Netherlands) Chair: L.D. Locati (Italy) 10:30 Nomogram for cumulative cisplatin dose for LAHNC receiving tri-weekly high-dose cisplatin CCRT T. Wang (Taiwan), M. Lien, C. Hua, H. Ching-Yun, T. Ming-Hsui 10:40 DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in p16- LAHNSCC M. Saksø (Denmark), K. Jensen, M. Andersen, J.G. Eriksen, J. Overgaard 10:50 Genomic characterization of oral premalignant lesions to identify high-risk molecular clusters P. Bossi (Italy), F. Perrone, M.S. Serafini, G. Pruneri, C. Piazza, L. Licitra, L. De Cecco 11:00 HNSCC in elderly frail patients treated by hafnium oxide nanoparticles activated by IMRT C. Hoffmann (France), V. Calugaru, V. Moreno Garcia, X. Mirabel, B. Doger de Spéville, E. Calvo, T. Jouffroy, J. Rodrigez, A. Chilles-Wang, M. Yemi, M. Lesnik, N. Badois, X. Liem, S. Salas, N. Fakhri, S. Wong Hee Khanà, C. Le Tourneau 11:10 Are elderly HNSCC patients undertreated? An analysis of outcomes using the SEER-Medicare database. I. Suzuki (USA), K. Cullen, S. Bentzen, O. Goloubeva 11:20 Socioeconomic inequality in head and neck cancer survival – a population-based study from DAHANCA M.H. Olsen (Denmark), P. Lassen, C. Rotbøl, T.K. Kjær, E.A.W. Andersen, J. Overgaard, S.O. Dalton

OC-040

OC-041

OC-042

OC-043

OC-044

OC-045

PROGRAMME & EXHIBITION GUIDE | SCIENTIFIC PROGRAMME

25